市场调查报告书
商品编码
1617088
2030 年溴苯市场预测:按产品类型、牌号、应用和地区分類的全球分析Bromobenzene Market Forecasts to 2030 - Global Analysis by Product Type (Phenylmagnesium Bromide, Bromobenzene Solutions, Alkyl Bromides, Aryl Bromides and Polybrominated Compounds), Grade, Application and By Geography |
根据Stratistics MRC预测,2024年全球溴苯市场规模将达12亿美元,预计2030年将达到17亿美元,预测期内复合年增长率为5.3%。
溴苯是一种有机化合物,化学式为C6H5Br,是一种无色液体,有刺激性气味。有机合成中用作溶剂和试剂。溴苯是由苯与溴在催化剂存在下反应生成的。它是一种用途广泛的化合物,用于各种化学反应,例如药物和农药的合成。
不断发展的製药业
溴苯是合成各种药物化合物(包括活性成分和试剂)的重要中间体。扩大医疗基础设施和增加全球研发投资正在增加对溴苯的需求。随着慢性病盛行率的上升和新药处方的推动,製药业继续推动溴苯的消费,特别是在已开发经济体和新兴经济体。预计这一趋势将在预测期内维持市场成长。
替代化学品
出于成本效益、可用性和环境友善等原因,具有类似应用的替代试剂和溶剂通常是首选。这些替代化学物质可以减少工业过程中对溴苯的依赖,特别是在成本敏感的市场。此外,有关化学品使用的严格规定限制了某些地区溴苯市场的成长,因为这进一步推动了向更安全替代品的转变。
特种化学品的扩张
溴苯广泛用于生产医药、农药和聚合物等特殊化学品。随着业界越来越多地寻求高性能、客製化的解决方案,溴苯在创新化学配方中找到了自己的位置。特种化学品产业的成长,特别是在投资先进製造和研发的地区,预计将在预测期内创造对溴苯的巨大需求。
原料成本波动
由于供需失衡、地缘政治问题或贸易限製而导致的价格波动可能会扰乱溴苯的生产和盈利。这种不确定性往往会影响製造商规划长期策略的能力,进而影响他们对下游产品的定价能力。这一因素仍然是市场的关键挑战,因为原材料成本是整体生产成本的关键决定因素。
由于供应链中断、工业活动减少和劳动力有限,COVID-19 大流行扰乱了溴苯市场。随着大流行措施收紧,製药业的需求部分抵消了这一下降。然而,一旦疫情过后产业復苏且生产水准恢復正常,在製药和特种化学品产业需求增加的推动下,市场开始恢復动力。
苯基溴化镁业务预计将在预测期内成为最大的业务
预计苯基溴化镁细分市场将在预测期内主导市场。这一优势归因于其在化学合成中的广泛应用,特别是在药物和特种化学品中。苯基溴化镁是一种重要试剂,广泛用于格氏反应产生高价值化合物。对复杂有机合成和高纯度试剂的需求不断增长也推动了该领域的崛起。
预计医药级细分市场在预测期间内复合年增长率最高
在预测期内,由于药品製造中对高纯度化合物的需求不断增加,预计药品级细分市场将呈现最高成长率。医药级溴苯广泛用作原料药合成的中间体。全球对医疗保健进步的关注以及製药业研发投资的增加正在推动该领域的成长。此外,对药品生产高品质原料的严格规定进一步增加了对药品级溴苯的需求。
预计北美地区将在预测期内主导市场。这得归功于该地区完善的製药和化学工业,以及对研发的大力投资。主要製造商的存在和强大的医疗基础设施进一步推动了对溴苯的需求。此外,支持先进化学应用的法律规范也有助于北美市场的主导地位。
预计亚太地区在预测期内的复合年增长率最高。这一增长是由中国和印度等国家的快速工业化、药品产量增加以及特种化学品市场不断扩大所推动的。具有成本效益的原材料的供应以及对开发先进製造能力的日益关注也进一步推动了该地区对溴苯的需求。
According to Stratistics MRC, the Global Bromobenzene Market is accounted for $1.2 billion in 2024 and is expected to reach $1.7 billion by 2030 growing at a CAGR of 5.3% during the forecast period. Bromobenzene is an organic compound with the chemical formula C6H5Br. It's a colorless liquid with a pungent odor. It's used as a solvent and a reagent in organic synthesis. Bromobenzene is produced by reacting benzene with bromine in the presence of a catalyst. It's a versatile compound used in various chemical reactions, including the synthesis of pharmaceuticals and agrochemicals.
Growing pharmaceutical industry
Bromobenzene serves as a critical intermediate in synthesizing various pharmaceutical compounds, including active ingredients and reagents. The expansion of healthcare infrastructure and increased R&D investment globally has escalated the demand for bromobenzene. With rising incidences of chronic diseases and the push for new drug formulations, the pharmaceutical sector continuously fuels the consumption of bromobenzene, especially in developed and emerging economies. This trend is expected to sustain market growth during the forecast period.
Substitute chemicals
Alternative reagents and solvents with similar applications are often preferred due to cost efficiency, availability, or environmental concerns. These substitutes can reduce dependency on bromobenzene in industrial processes, especially in cost-sensitive markets. Additionally, stringent regulations on chemical usage further encourage the shift towards safer alternatives, thereby limiting bromobenzene's market growth in certain regions.
Expanding of specialty chemicals
Bromobenzene is widely used in producing specialty chemicals for applications in pharmaceuticals, agrochemicals, and polymers. As industries increasingly require high-performance and tailored solutions, bromobenzene finds its place in innovative chemical formulations. Growth in the specialty chemicals sector, especially in regions investing in advanced manufacturing and R&D, is expected to create substantial demand for bromobenzene during the forecast period.
Cost fluctuation of raw materials
Price volatility due to supply-demand imbalances, geopolitical issues, or trade restrictions can disrupt the production and profitability of bromobenzene. This uncertainty often impacts manufacturers' ability to plan long-term strategies and affects the pricing dynamics of downstream products. As raw material costs are a significant determinant of overall production costs, this factor remains a critical challenge for the market.
The Covid-19 pandemic disrupted the bromobenzene market due to supply chain interruptions, reduced industrial activities, and limitations in workforce availability. The pharmaceutical industry's demand partially offset this decline as efforts to combat the pandemic intensified. However, as industries recovered post-pandemic and production levels normalized, the market began to regain momentum, driven by increasing demand from pharmaceuticals and specialty chemicals sectors.
The phenylmagnesium bromide segment is expected to be the largest during the forecast period
Over the forecasted timeframe, the phenylmagnesium bromide segment is anticipated to dominate the market. This dominance is attributed to its extensive applications in chemical synthesis, particularly in pharmaceuticals and specialty chemicals. Phenylmagnesium bromide, an essential reagent, is widely used in Grignard reactions for producing high-value compounds. The growing demand for complex organic synthesis and high-purity reagents further supports this segment's prominence.
The pharmaceutical grade segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the pharmaceutical grade segment is predicted to witness the highest growth rate due to the increasing demand for high-purity compounds in drug manufacturing. Pharmaceutical-grade bromobenzene is extensively utilized as an intermediate in synthesizing active pharmaceutical ingredients. The global emphasis on healthcare advancements, coupled with rising R&D investments in the pharmaceutical sector, drives this segment's growth. Additionally, stringent regulations necessitating high-quality inputs in drug production further enhance the demand for pharmaceutical-grade bromobenzene.
During the estimation period, the North America region is anticipated to dominate the market. This is due to the region's well-established pharmaceutical and chemical industries, coupled with significant investments in R&D. The presence of key manufacturers and a robust healthcare infrastructure further drive bromobenzene demand. Additionally, regulatory frameworks supporting advanced chemical applications contribute to the market's dominance in North America.
During the forecast period, the Asia Pacific region is anticipated to register the highest CAGR. This growth is driven by rapid industrialization, increasing pharmaceutical production, and expanding specialty chemical markets in countries like China and India. The availability of cost-effective raw materials and a growing emphasis on developing advanced manufacturing capabilities further boost bromobenzene's demand in the region.
Key players in the market
Some of the key players in Bromobenzene Market include Hawks Chemical Co Ltd, Alfa Aesar, Merck KGaA, ExxonMobil Corporation, Sontara Organo Industries, Tokyo Chemical Industry Co., Ltd., Weifang Yonhop Chemical Co., Ltd., Shandong Henglian Chemical Co., Ltd., Heranba Industries Ltd., Shanghai Wescco Chemical Co., Ltd., ChemSampCo Inc., Aarti Industries Limited, Solvay S.A., Jiangsu Tianxin Chemical Co., Ltd., Arkema Group, Eastman Chemical Company, and Lanxess AG.
In October 2024, Merck, a leading science and technology company, announced a € 70 million expansion of its ADC manufacturing capabilities and capacity at its Bioconjugation Center of Excellence facility in St. Louis, Missouri, USA. This investment will triple existing capacity and enhance the company's contract development and manufacturing organization (CDMO) offering, reinforcing its commitment to clients and patients.
In May 2024, Arkema has agreed to acquire Dow's flexible packaging laminating adhesives business, one of the leading producers of adhesives for the flexible packaging market, generating annual sales of around US$250 million. The proposed acquisition will significantly expand Arkema's portfolio of solutions for flexible packaging, enabling the Group to become a key player in this attractive market.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.